Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GenoPhe is a precision medicine biotechnology company focused on the diagnosis and therapeutic management of rare genetic diseases. The company utilizes a proprietary multi-omics platform that integrates genomics and proteomics to identify specific biomarkers and potential therapeutic targets for underserved patient populations. Based in Bangalore, India, GenoPhe provides advanced diagnostic services and partners with clinical researchers to accelerate the discovery of personalized treatments. Their approach aims to reduce the diagnostic odyssey for patients with complex metabolic and genetic disorders through data-driven insights. By bridging the gap between molecular data and clinical application, GenoPhe supports the development of targeted interventions in the rare disease space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DR GAYATHRI SAGAR.